Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Nkarta, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- −9 vs. Q2 2022
- Shares held
- 42.7M
- −869.1K (−2.0%) vs. Q2 2022
- Total value
- $561.5M
- +$25.0M (+4.7%) vs. Q2 2022
- New holders
- 11
- 37 more added
- Sold out
- 20
- 28 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 2,814,844 | $37.0M | 1.83% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 2,868,035 | $37.7M | 8.81% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,571,640 | $47.0M | 2.35% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 4,003,344 | $52.7M | 0.04% | +4,003,344 | New |
| Ra Capital Management, L.P. | 7,805,129 | $102.7M | 2.19% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −3,879,662−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −143,383−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −107,307−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −46,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −37,270−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −33,717−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −31,242−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −14,943−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −14,032−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,131−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −12,459−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,508−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,547−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,561−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,962−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −182−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| BFT Financial Group, LLC | – | – | – | – | Not filed |